Newsroom
Sorted by: Latest
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust United Kingdom AlphaDEX UCITS ETF 26.06.2026 FKUD IE00BD9N0445 121,463.00 GBP 3,654,834.53 30.090 ...
-
Precision BioSciences Announces Inclusion in the Russell 2000® Index Expanding Market Visibility with Institutional Investors
DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today announced its addition to the Russell 2000® Index, effective at the close of U.S. equity markets on June 26, 2026, according to the final list of additions published by FTSE Russell. The annual reconstitution of the Russell U.S. indexes ranks eligible U.S. sto...
-
FHLBank Chicago Opens Applications for $3 Million Developer Program to Grow Affordable Housing Talent Pipeline
CHICAGO--(BUSINESS WIRE)--The Federal Home Loan Bank of Chicago (FHLBank Chicago) today opened applications for its 2026 Community First® Developer Program (Developer Program), a grant initiative that helps organizations train and develop the next generation of affordable housing professionals across Illinois and Wisconsin. FHLBank Chicago will award up to $3 million, delivered through its financial institution members to eligible organizations. Grants will range from $50,000 to $200,000, and a...
-
KnowBe4 Expands Gamified Training Library With Launch of "Spot the Vish" Game
TAMPA BAY, Fla.--(BUSINESS WIRE)--KnowBe4, the global leader in digital workforce security, securing both AI agents and humans, today announced the official launch of its 35th interactive game, Spot the Vish. This latest addition to the KnowBe4 game library is designed to train the digital workforce to recognize, resist, and report voice phishing (vishing) attacks in real time. Vishing attacks have grown increasingly sophisticated, often involving bad actors posing as IT support or C-level exec...
-
Concorde Names Marc Morell Chief Compliance Officer
ANN ARBOR, Mich.--(BUSINESS WIRE)--Concorde Investment Services, a leading independent broker-dealer and registered investment advisor serving financial professionals nationwide, has hired Marc A. Morell as chief compliance officer."Marc brings exactly the kind of seasoned, hands-on compliance leadership Concorde needs as we continue to grow," said Danielle Delongchamp, president and chief executive officer of Concorde. "His depth of experience leading broker-dealer compliance, advisor governanc...
-
MANE Selects Kinaxis to Strengthen Global Planning Capabilities
OTTAWA, Ontario--(BUSINESS WIRE)--Kinaxis® (TSX:KXS), a global leader in end-to-end supply chain planning and orchestration, today announced that MANE, one of the top five leading organizations worldwide in the flavours and fragrances industry, has selected Kinaxis to modernize its planning capabilities as it accelerates global growth as part of a broader enterprise-wide transformation initiative. Headquartered in the south of France, with a significant global footprint spanning multiple region...
-
SES AI Announces Inclusion in Russell 3000®Index
WOBURN, Mass.--(BUSINESS WIRE)--SES AI Corporation (“SES AI,” the “Company,” “we” or “us”) (NYSE: SES), a global leader in the development and manufacturing of AI-enhanced high-performance Li-Metal and Li-ion batteries, today announced that it has been added to the Russell 3000® Index. The newly reconstituted Russell 3000® Index will begin trading at the market open on Monday, June 29, 2026. Russell indexes are widely used by investment managers and institutional investors for index funds and a...
-
The Winn-Dixie Company donates $100,000 to the USO ahead of Independence Day
JACKSONVILLE, Fla.--(BUSINESS WIRE)--The Winn-Dixie Company donates $100,000 to the USO ahead of Independence Day...
-
Neurogene Reports Positive Long-term Clinical Data from Phase 1/2 Trial of NGN-401 Gene Therapy for Rett Syndrome
NEW YORK--(BUSINESS WIRE)--Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced updated, positive data from its Phase 1/2 clinical trial evaluating NGN-401 gene therapy for the treatment of females with Rett syndrome. Across 10 participants, 47 total developmental milestones were gained (average of 4.7 per participant), with both pediatric and adolescent/adult par...
-
Palladyne AI’s GuideTech Wins New $2.3 Million Contract for BRAIN with Defense Prime Continuing Commercial Momentum
SALT LAKE CITY--(BUSINESS WIRE)--Palladyne AI (NASDAQ: PDYN), a U.S.-based defense and industrial technology company delivering embodied AI-powered collaborative autonomy solutions, advanced avionics, precision-manufactured components, UAVs, and advanced aerospace design services, today announced that its subsidiary, GuideTech, has secured a new $2.3 million contract with a defense prime contractor to deploy its BRAIN flight computer and FLEX flight software framework in support of development,...